DiaMedica Therapeutics Inc. (NASDAQ:DMAC) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Richard Kuntz Other companies: Identiv, Inc. (Director · Since at least Oct 18, 2022); ZimVie Inc (Director · Since at least Mar 1, 2022); Rockley Photonics Holdings Ltd (Director · Aug 8, 2022 – Aug 8, 2022 · Past); Medtronic plc. (SVP & Chief Medical & Science · Jan 9, 2018 – Nov 5, 2021 · Past) | Director · Since at least May 30, 2023 |
| Amy Burroughs Other companies: Terns Pharmaceuticals, Inc. (Chief Executive Officer, Director · Since at least Feb 7, 2024); Tenaya Therapeutics, Inc. (Board Member · Since at least Dec 5, 2022) | Director · Jul 15, 2021 – Jan 3, 2023 · Past |
| Daniel O’Connor Other companies: Ambrx Biopharma Inc. (President and CEO, Director · Jan 1, 2023 – Mar 7, 2024 · Past); ZyVersa Therapeutics, Inc. (Director · Dec 20, 2021 – Dec 12, 2022 · Past) | Director · Since at least Feb 20, 2025 |
| James Parsons Other companies: Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); Trillium Therapeutics Inc (Chief Financial Officer · Jan 1, 2021 – Nov 17, 2021 · Past) | Chairman of the Board · Since at least Dec 6, 2018 |
| Julie Krop Other companies: Aquestive Therapeutics, Inc. (Aquestive Director, and Chief Medical Officer of DiaMedica Therapeutics, Inc. · Since at least Feb 10, 2021); AMAG Pharmaceuticals Inc (Chief Medical Officer · Jun 1, 2015 – Mar 2, 2020 · Past) | Chief Medical Officer · Since at least Aug 11, 2025 |
| Masuoka K Lorianne Other companies: Opiant Pharmaceuticals Inc (Director · Mar 18, 2021 – Mar 2, 2023 · Past); Marinus Pharmaceuticals Inc (Chief Medical Officer · Dec 6, 2017 – Aug 21, 2019 · Past) | Chief Medical Officer · Jan 22, 2024 – Jan 22, 2024 · Past |
| David Wambeke Other companies: NeuroOne Medical Technologies Corporation (Chief Business Officer · Since at least Mar 1, 2026) | Chief Business Officer · Since at least Apr 10, 2023 |
| Scott Kellen Other companies: Kips Bay Medical Inc (COO, CFO, VP of Finance & Secy · Feb 10, 2011 – Mar 10, 2015 · Past) | Chief Financial Officer · Since at least Dec 6, 2018 |
| Tanya Lewis Other companies: Replimune Group, Inc. (Chief Dev. Op. Officer · Apr 1, 2022 – Jun 13, 2023 · Past) | Director · Since at least Mar 1, 2023 |
| Ambarish Shah | Chief Technology Officer · Since at least Nov 5, 2026 |
| Charles Semba | Director · Since at least Jul 15, 2021 |
| Dietrich John Pauls | President & CEO, Director · Since at least Dec 6, 2018 |
| Dominic Cundari | Chief Commercial Officer · Since at least Feb 1, 2022 |
| Harry W Alcorn Jr | SVP, Clinical Operations · Dec 6, 2018 – Sep 15, 2021 · Past |
| Julie VanOrsdel Daves | SVP Clinical Development Oper. · Sep 13, 2022 – Jun 1, 2023 · Past |
| Kirsten L Gruis | Chief Medical Officer · Jan 3, 2022 – Jun 1, 2023 · Past |
| Michael Giuffre | Director · Since at least Nov 5, 2026 |
| Randall Michael Giuffre | Director · Since at least Dec 6, 2018 |
| Richard D Pilnik | Director · Dec 6, 2018 – Apr 7, 2025 · Past |
| Rick Pauls | President & CEO · Since at least Oct 22, 2026 |
| Sydney A Gilman | VP, Regulatory Affairs · Nov 1, 2019 – Jul 28, 2021 · Past |
| Todd A Verdoorn | Chief Scientific Officer · Dec 6, 2018 – Jun 24, 2019 · Past |
| Zhenyu Xiao | Director · Dec 6, 2018 – Jun 24, 2019 · Past |